Results 121 to 130 of about 1,213,487 (359)

The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer. [PDF]

, 2012
Summary In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast cancer patient cohort of 82 breast cancer patients. Immunohistochemical analysis was possible in 91.5% of the patients (75/82). Staining was evaluated using
Berger U, Berger U, Boecker W, Conde I, Eisman JA, Frampton RJ, Freake HC, Gombart AF, Jeschke U, Mason BH, Mylonas I, Remmele W, Ulmann A, Zinser GM   +13 more
core   +2 more sources

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Progression‐free survival (PFS) in oncology: caveat emptor! [PDF]

Basic & Clinical Pharmacology & Toxicology, 2019
Mark A. Ainsworth, Mark A. Ainsworth, Sinan B. Sarac, Doris Hovgaard, Ole W. Bjerrum   +4 more
openaire   +4 more sources

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

What does the post radiotherapy prostate specific antigen (PSA) nadir tell us about progression-free-survival in patients with localized cancer [PDF]

, 2001
Kassandra Doyle, Mack Roach, Vivian Weinberg, Patrick W. McLaughlin, Howard M. Sandler   +4 more
openalex   +1 more source

Progression-free survival in the ICON8 trial – Authors' reply [PDF]

The Lancet, 2020
James, EC, McNeish, IA, Cook, AD, Kaplan, R, Clamp, AR   +4 more
openaire   +5 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Multi-institutional validation of a radiomics signature for identification of postoperative progression of soft tissue sarcoma

Cancer Imaging
Background To develop a magnetic resonance imaging (MRI)-based radiomics signature for evaluating the risk of soft tissue sarcoma (STS) disease progression.
Yuan Yu, Hongwei Guo, Meng Zhang, Feng Hou, Shifeng Yang, Chencui Huang, Lisha Duan, Hexiang Wang   +7 more
doaj   +1 more source

Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma [PDF]

, 2001
Christophe Louvet, Aimery de Gramont, Christophe Tournigand, Pascal Artru, Frédérique Maindrault‐Gœbel, M Krulik   +5 more
openalex   +1 more source

PRM12 Joint Estimation of Progression Free Survival and Overall Survival [PDF]

Value in Health, 2012
G. Bergman, M.J. Ouwens
openaire   +2 more sources